Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 542 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

UCB licenses global rights to Tozadenant

The move represents an earlier collaborative deal between the companies, which was signed in 2010, and will provide financial resources to Biotie to carry out phase 3 development

Baxter seeks FDA approval for FEIBA NF drug

The firm recently released results from the pivotal Phase III study, which formed the basis for the BLA submission. The study demonstrated that routine prophylactic treatment with FEIBA

Hospira recalls five different injections

According to the firm, the recall was took place as the consumers have reported that one lot of preservative-free morphine sulfate injection has experienced problems with a loose

FDA accepts Antares NDA for OTREXUP

OTREXUP drug delivers methotrexate (MTX) using a proprietary parenteral drug delivery system Medi-Jet technology. Medi-Jet enables patients to self-administer a drug subcutaneously or intramuscularly, while also enhancing safety